1Wright L,Stauffer N,Samai C, et al. Who should be re- ferred? An evaluation of referral indications for fetal ech ocardiography in the detection of structural congenital heart disea se[J]. Pediatr Cardiol, 2014,35 (6) : 928-933.
2Dahlback C, Pihlsgard M, Gudmundsson S. Abnormal ductus venosus pulsatility index in the absence of concur- rent umbilical vein pulsations does not indicate worsening fetal conditio n[J]. Ultrasound Obstet Gynecol, 2013,42 (3) :322-328.
5Iruretagoyena JI, Davis W, Bird C, et al. Metabolic gene profile in early human fetal heart development [J].Mol Hum Reprod,2014,20(7) :690-700.
6Liu H, Huang TT,Zhao WX,et al. Pregnancy outcomes and relative risk factors among Chinese women with con- genital heart disease [J]. Ultrasound Obstet Gynecol, 2013,120(3) :245-248.
7Mogra R, Alabbad N, Hyett J. Increased nuchal translu cency and congenital heart disease[J]. Early Hum Dev, 2012,88(5) :261- 267.
8J elliffe-pawlowski LL, Nortoon ME, Shaw GM, et al. Risk of critical congenital heart defects by nuchal translucency norms[J]. Am J Ohstet Gynecol,2014,32(1) :110-115.
9Papathepdprou SI, Evangelou E, Makrydimas G, et al. First-trimester ductus venosus screening for cardiac de- fects: a meta analysis[J]. BJOG, 2011, 118 (12): 1438- 1445.
10Chelemen T, Syngelaki A, Maiz N, et al. Contribution of ductus venosus Doppler in first-trimester screening for major cardiac defects[J]. Fetal Diagn Ther, 2011,29 (2) : 127-134.
7Cuneo BF,Curran LF,Davis N,et al. Trends in prenatal diagnosis of critical cardiac defects in an integrated obstetric and pediatric cardiac imaging center[J]. J Perinatol,2004,24:674-678.
8Hyett J, Perdu M, Sharland G, et al. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation : population based cohort study [ J ]. BMJ, 1999,318:81-85.
9Haak MC, Twisk JWR, van Vugt JMG. How successful is fetal echocardiographic examination in the first trimester of pregnancy [J]. Ultrasound Obstet Gynecol,2002 ,20 :9-13.
10Chaoui R. The four-chamber view: four reasons why it seems to fail in screening for cardiac abnormalities and suggestions to improve detection rate [ J ]. Ultresound Obstet Gynecol, 2003,22 (1) :3-10.
3Wright L, Stauffer N, Samai C,etal. Who should be referred? An evaluation of referral indications for fetal echocardiography in the detection of structural congenital heart disease [J ]. Pediatr Cardiol,2014,35(6) :928-933.
4Nelle M, Raio L, Pavlovic M, et al. Prenatal diagnosis and treatment planning of congenital heart defects-possibilities and limits[J]. World J Pediatr, 2009,5 (1) .. 18-22.
5Li Y, Hua Y, Fang J, et al. Performance of different scanprotocols of fetal echocardiography in the diagnosis of fetal congenital heart disease:a systematic review and meta-analysis[J]. PLoS 0ne,2013,8(6) :e65484.
6Marek J, Tomek V, Skovrclnek J,et al. Prenatal ultrasound screening of congenital heart disease in an unselected national population: a 21-year experienee[J].Heart, 2011,97 (2) : 124- 130.
7Zhou K, Wu G, Li Y,et al. Protective effects of indomethacin and dexamethasone in a goat model with intrauterine balloon aortic valvuloplasty[J]. J Biomed Sci, 2012,19 (1) : 74.
8Zhou K, Zhou R, Zhu Q,etal. Evaluation of therapeutic effect and cytokine change during transplacental Digoxin treatment for fetal heart failure associated with fetal tachycardia, a case- control study[J]. Int J Cardiol,2013,169(4):e62-e64.
